Seizert Capital Partners’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-4,400
| Closed | -$280K | – | 167 |
|
2024
Q2 | $280K | Sell |
4,400
-605
| -12% | -$38.5K | 0.01% | 145 |
|
2024
Q1 | $346K | Hold |
5,005
| – | – | 0.02% | 140 |
|
2023
Q4 | $276K | Sell |
5,005
-1,395
| -22% | -$76.9K | 0.01% | 159 |
|
2023
Q3 | $372K | Buy |
6,400
+2,003
| +46% | +$116K | 0.02% | 142 |
|
2023
Q2 | $237K | Buy |
+4,397
| New | +$237K | 0.01% | 168 |
|
2020
Q3 | – | Sell |
-29,902
| Closed | -$967K | – | 191 |
|
2020
Q2 | $967K | Sell |
29,902
-4,969
| -14% | -$161K | 0.07% | 115 |
|
2020
Q1 | $1.42M | Sell |
34,871
-3,060
| -8% | -$125K | 0.1% | 85 |
|
2019
Q4 | $2.34M | Sell |
37,931
-1,114
| -3% | -$68.7K | 0.12% | 84 |
|
2019
Q3 | $2.85M | Buy |
39,045
+9,648
| +33% | +$703K | 0.14% | 81 |
|
2019
Q2 | $2.42M | Buy |
+29,397
| New | +$2.42M | 0.12% | 87 |
|